iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Short Interest Down 34.0% in April

Posted by Stacy Sanders on May 18th, 2026

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN – Get Free Report) saw a significant decline in short interest in the month of April. As of April 30th, there was short interest totaling 1,522 shares, a decline of 34.0% from the April 15th total of 2,307 shares. Currently, 1.0% of the shares of the company are short sold. Based on an average daily volume of 1,233 shares, the days-to-cover ratio is currently 1.2 days.

iShares Neuroscience and Healthcare ETF Stock Performance

NYSEARCA IBRN opened at $34.79 on Monday. The firm has a market cap of $5.22 million, a PE ratio of 15.61 and a beta of 0.77. iShares Neuroscience and Healthcare ETF has a one year low of $21.78 and a one year high of $37.00. The firm’s fifty day moving average is $33.44 and its two-hundred day moving average is $32.22.

iShares Neuroscience and Healthcare ETF Company Profile

(Get Free Report)

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.